DATA IMAGES SOFTWARE SOLUTIONS LTD
Company number 07013789 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Score: B-
Explanation: The company exhibits the vital signs of a profitable but financially stretched entity. While it possesses a strong "heart" (evidenced by robust profitability leading to significant dividend payouts), it suffers from "low blood pressure" in the form of a working capital deficiency. Furthermore, the company's "bone density" is highly reliant on intangible assets, which can be subject to sudden impairment if commercial conditions change. The recent shift to Dormant status suggests the patient has been placed in an induced hibernation, but the underlying financial anatomy from its last active period shows both resilience and areas of concern.
Key Vital Signs
- Current Ratio (Liquidity/Blood Pressure): 0.77x Current Assets (£133,405) divided by Current Liabilities (£173,891). A reading below 1.0 indicates that the company does not have enough short-term assets to cover its near-term debts. This is a symptom of "working capital anemia," meaning the company is relying on cash flow from operations or long-term financing to keep the lights on, rather than a healthy buffer of liquid assets.
- Net Assets (Financial Bone Mass): £251,616 The company is in positive equity territory, which is a good sign of overall structural integrity. However, £418,155 of the total assets are intangible (capitalized software development costs). If the software fails to generate future economic benefits, these assets could suffer sudden "fractures" (impairment), drastically reducing the net asset base.
- Cash Position (Fluid Reserves): £85,268 Cash levels are reasonable but are overshadowed by the £76,931 in short-term bank loans and £21,000 in trade creditors. The patient has enough fluid to function day-to-day, but has little margin for error if revenue stalls.
- Dividend Payout (Bloodletting): £261,293 The directors extracted over a quarter of a million pounds in dividends in 2020. While a sign of a strong profit-generating heart, paying out this magnitude of cash while operating with negative working capital is the financial equivalent of bleeding the patient while they are already suffering from low blood pressure.
Diagnosis
Condition: Acute Working Capital Deficiency with Intangible Asset Dependency
The financial data reveals a business that is operationally profitable but financially fragile. The primary symptom of distress is the negative working capital (£40,486 deficit). In medical terms, the company is living "hand to mouth"—paying short-term debts directly from incoming cash flow rather than from a healthy reserve of current assets.
The balance sheet is heavily "top-heavy" with intangible assets. The £418,155 capitalized in R&D represents the company's intellectual property, but it is not easily convertible to cash in an emergency. The patient is carrying a lot of muscle, but it is the kind that cannot be quickly converted into energy (liquidity) when needed.
The most alarming symptom is the dividend policy. Extracting £261,293 in dividends while holding negative working capital suggests that the directors prioritized personal extraction over balance sheet resilience. While legal (as the company remains solvent), this practice leaves the business highly vulnerable to unexpected shocks.
Finally, current Companies House data indicates the company is now classified as "Dormant." This suggests the patient has been placed in a medically induced coma—trading has ceased or paused, likely rendering the working capital concerns temporarily moot, but raising questions about the future recoverability of those substantial capitalized development costs.
Recommendations
- Halt the "Bloodletting": If or when the company comes out of its dormant state, dividends must be restricted until the working capital deficit is cured. Retained profits should be used to build up cash reserves and pay down short-term creditors to achieve a current ratio of at least 1.2x.
- Impairment Check-Up: Given the Dormant status, a thorough review of the £418k in capitalized development costs is critical. If the software is no longer being actively sold or developed, these assets may need to be impaired. Failing to recognize an impairment is like ignoring a healed bone that has set incorrectly—it will misrepresent the true health of the patient.
- Debt Restructuring: The company has £76k in short-term bank loans and £150k in long-term bank loans. If operations resume, negotiating with lenders to extend the term of the short-term debt would provide immediate relief to the working capital deficit, effectively lowering the patient's blood pressure to a safer level.